DILOPAX

This brand name is authorized in Nigeria.

Active ingredients

The drug DILOPAX contains one active pharmaceutical ingredient (API):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2915	Tablet	DILOPAX 10MG TABLETS TAB 10 mg 310packs	DILOPAX 10MG TABLETS AMLODIPINE BESYLATE 10MG TABLETS AMLODIPINE BESYLATE 10MG TABLETS. SODIUM STARCH GLYCOLATE . CALCIUM HYDROGEN PHOSPHATE ANHYDROUS CELLULOSE MICROCRYSTALLINE MAGNESIUM STEARATE. A4-2915 Drugs Imported Products 310packs POM 1 15/06/2022 KORLYNS PHARMACEUTICALS LIMITED, 7, JAIYE OYEDOTUN STREET, MAGODO LAGOS LAGOS 8123173544 hardeybeecee77@yahoo.com CRIS PHARMA (INDIA) LTD, E-11,UPSIDC, INDUSTRIAL AREA,SELAQUI, DEHRADUN,UTTARAKHAND,INDIA, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08CA01	Amlodipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-2915